**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Transplantation Surgery**
Led by authors from MD Anderson’s Stem Cell Transplantation and Cellular Therapy Department, the world’s largest and highly respected program at the forefront of rapidly advancing treatments in the field, Manual of Hematopoietic Cell Transplantation and Cellular Therapies is a comprehensive, focused reference covering the latest clinical developments and applications of stem cell transplant and cellular therapies for hematologic malignancies and solid tumors. This cutting-edge title, with a majority contribution from the MD Anderson Cancer Center and leading faculty from other academic institutions, covers breakthrough cell-based therapies for various diseases including lymphoma, multiple myeloma, leukemia, and select solid tumor and autoimmune diseases. This unique, definitive resource is essential for hematologists, fellows in hematology and immunotherapy, mid-level providers, pharmacists, and oncologists who refer patients for cell-based therapies.
1. Part I: Introduction and Biological Aspects - p. xii 2. 1. Hematopoietic Transplantation: Past, Present, and Future - p. 3 3. 2. Role of the Human Leukocyte Antigen System in Hematopoietic Stem Cell Transplantation - p. 17 4. Part II: Methodology - p. 23 5. 3. Hematopoietic Cell Collection - p. 29 6. 4. Bayesian Statistical Methods in Stem Cell Transplantation and Cellular Therapy - p. 39 7. Part III: General Clinical Aspects - p. 51 8. 5. Patient and Donor Assessments in Preparation for Transplant - p. 55 9. 6. Transfusion Support During Hematopoietic Cell Transplantation - p. 67 10. 7. Haploidentical Hematopoietic Cell Transplantation - p. 83 11. 8. Umbilical Cord Blood Transplantation - p. 101 12. 9. Process and General Management of Patients Undergoing Chimeric Antigen Receptor Therapies - p. 115 13. Part IV: Pharmacology and Radiation Therapy - p. 121 14. 10. Preparative Regimens Used in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapies - p. 125 15. 11. Pharmacology of Drugs Used in Hematopoietic Cell Transplant and Chimeric Antigen Receptor Therapies - p. 145 16. 12. Radiobiologic Principles and the Role of Radiotherapy in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy - p. 167 17. Part V: Disease-Specific Indications and Results - p. 175 18. 13. Hematopoietic Cell Transplantation in Adult With Acute Myeloid Leukemia - p. 183 19. 14. Chimeric Antigen Receptor Therapy in Acute Myeloid Leukemia - p. 205 20. 15. Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia - p. 217 21. 16. Chimeric Antigen Receptor T-Cell Therapy in Acute Lymphoblastic Leukemia - p. 233 22. 17. Hematopoietic Cell Transplantation and Other Cellular Therapies for Chronic Lymphocytic Leukemia - p. 247 23. 18. Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome Patients - p. 263 24. 19. Allogeneic Cell Transplantation for Myeloproliferative Neoplasms - p. 279 25. 20. Hematopoietic Cell Transplantation in Aplastic Anemia - p. 287 26. 21. Hematopoietic Cell Transplantation in Multiple Myeloma - p. 297 27. 22. Chimeric Antigen Receptor Therapy in Multiple Myeloma - p. 309 28. 23. Hematopoietic Cell Transplantation in Light Chain Amyloidosis - p. 331 29. 24. Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma - p. 341 30. 25. Hematopoietic Cell Transplantation for Hodgkin Lymphoma - p. 357 31. 26. Chimeric Antigen Receptor Therapy in Lymphoma - p. 371 32. 27. Hematopoietic Cell Transplantation in Rare Hematologic Malignancies - p. 383 33. 28. Hematopoietic Cell Transplantation for Germ-Cell Tumors and Other Adult Solid Tumors - p. 395 34. 29. Natural Killer Cells: A Promising Cellular Therapy Platform to Conquer Cancer - p. 403 35. Part VI: Prevention and Management of Complications - p. 408 36. 30. Infection Control, Prophylaxis, and Vaccinations in Hematopoietic Cell Transplantation Recipients - p. 413 37. 31. Management of Infections in Stem Cell Transplant Recipients - p. 429 38. 32. Graft Failure After Hematopoietic Cell Transplantation - p. 443 39. 33. Graft-Versus-Host Disease - p. 453 40. 34. Miscellaneous Complications of Hematopoietic Cellular Transplantation - p. 481 41. 35. Cytokine Release Syndrome Following CD19 Directed Chimeric Antigen Receptor T-Cell Therapy - p. 509 42. 36. Neurologic Complications of Chimeric Antigen Receptor Therapy - p. 525 43. 37. Miscellaneous Complications of Chimeric Antigen Receptor T-Cell Therapy - p. 537 44. 38. Symptom Management and Palliative Care in Hematologic Malignancies - p. 549 45. 39. Survivorship - p. 561 46. Index - p. 573 47. Confidence is ClinicalKey - p. 591
**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Transplantation Surgery**
Led by authors from MD Anderson’s Stem Cell Transplantation and Cellular Therapy Department, the world’s largest and highly respected program at the forefront of rapidly advancing treatments in the field, Manual of Hematopoietic Cell Transplantation and Cellular Therapies is a comprehensive, focused reference covering the latest clinical developments and applications of stem cell transplant and cellular therapies for hematologic malignancies and solid tumors. This cutting-edge title, with a majority contribution from the MD Anderson Cancer Center and leading faculty from other academic institutions, covers breakthrough cell-based therapies for various diseases including lymphoma, multiple myeloma, leukemia, and select solid tumor and autoimmune diseases. This unique, definitive resource is essential for hematologists, fellows in hematology and immunotherapy, mid-level providers, pharmacists, and oncologists who refer patients for cell-based therapies.
1. Part I: Introduction and Biological Aspects - p. xii 2. 1. Hematopoietic Transplantation: Past, Present, and Future - p. 3 3. 2. Role of the Human Leukocyte Antigen System in Hematopoietic Stem Cell Transplantation - p. 17 4. Part II: Methodology - p. 23 5. 3. Hematopoietic Cell Collection - p. 29 6. 4. Bayesian Statistical Methods in Stem Cell Transplantation and Cellular Therapy - p. 39 7. Part III: General Clinical Aspects - p. 51 8. 5. Patient and Donor Assessments in Preparation for Transplant - p. 55 9. 6. Transfusion Support During Hematopoietic Cell Transplantation - p. 67 10. 7. Haploidentical Hematopoietic Cell Transplantation - p. 83 11. 8. Umbilical Cord Blood Transplantation - p. 101 12. 9. Process and General Management of Patients Undergoing Chimeric Antigen Receptor Therapies - p. 115 13. Part IV: Pharmacology and Radiation Therapy - p. 121 14. 10. Preparative Regimens Used in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapies - p. 125 15. 11. Pharmacology of Drugs Used in Hematopoietic Cell Transplant and Chimeric Antigen Receptor Therapies - p. 145 16. 12. Radiobiologic Principles and the Role of Radiotherapy in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy - p. 167 17. Part V: Disease-Specific Indications and Results - p. 175 18. 13. Hematopoietic Cell Transplantation in Adult With Acute Myeloid Leukemia - p. 183 19. 14. Chimeric Antigen Receptor Therapy in Acute Myeloid Leukemia - p. 205 20. 15. Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia - p. 217 21. 16. Chimeric Antigen Receptor T-Cell Therapy in Acute Lymphoblastic Leukemia - p. 233 22. 17. Hematopoietic Cell Transplantation and Other Cellular Therapies for Chronic Lymphocytic Leukemia - p. 247 23. 18. Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome Patients - p. 263 24. 19. Allogeneic Cell Transplantation for Myeloproliferative Neoplasms - p. 279 25. 20. Hematopoietic Cell Transplantation in Aplastic Anemia - p. 287 26. 21. Hematopoietic Cell Transplantation in Multiple Myeloma - p. 297 27. 22. Chimeric Antigen Receptor Therapy in Multiple Myeloma - p. 309 28. 23. Hematopoietic Cell Transplantation in Light Chain Amyloidosis - p. 331 29. 24. Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma - p. 341 30. 25. Hematopoietic Cell Transplantation for Hodgkin Lymphoma - p. 357 31. 26. Chimeric Antigen Receptor Therapy in Lymphoma - p. 371 32. 27. Hematopoietic Cell Transplantation in Rare Hematologic Malignancies - p. 383 33. 28. Hematopoietic Cell Transplantation for Germ-Cell Tumors and Other Adult Solid Tumors - p. 395 34. 29. Natural Killer Cells: A Promising Cellular Therapy Platform to Conquer Cancer - p. 403 35. Part VI: Prevention and Management of Complications - p. 408 36. 30. Infection Control, Prophylaxis, and Vaccinations in Hematopoietic Cell Transplantation Recipients - p. 413 37. 31. Management of Infections in Stem Cell Transplant Recipients - p. 429 38. 32. Graft Failure After Hematopoietic Cell Transplantation - p. 443 39. 33. Graft-Versus-Host Disease - p. 453 40. 34. Miscellaneous Complications of Hematopoietic Cellular Transplantation - p. 481 41. 35. Cytokine Release Syndrome Following CD19 Directed Chimeric Antigen Receptor T-Cell Therapy - p. 509 42. 36. Neurologic Complications of Chimeric Antigen Receptor Therapy - p. 525 43. 37. Miscellaneous Complications of Chimeric Antigen Receptor T-Cell Therapy - p. 537 44. 38. Symptom Management and Palliative Care in Hematologic Malignancies - p. 549 45. 39. Survivorship - p. 561 46. Index - p. 573 47. Confidence is ClinicalKey - p. 591
